A systematic review of the cost-effectiveness of perampanel in the treatment of epilepsy
A systematic review of the cost-effectiveness of perampanel in the treatment of epilepsy
Epilepsy is a chronic non-communicable disease that can affect all ages, genders, races, and social classes with large treatment costs that vary widely between countries and regions. Perampanel is a new generation of antiepileptic drugs (AEDs), but cost-effectiveness reports are inconsistent in several countries that have conducted pharmacoeconomic evaluations.